Dexmedetomidine + Normal Saline
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Spine Surgery
Conditions
Spine Surgery
Trial Timeline
Feb 1, 2008 → May 1, 2010
NCT ID
NCT00494832About Dexmedetomidine + Normal Saline
Dexmedetomidine + Normal Saline is a pre-clinical stage product being developed by Pfizer for Spine Surgery. The current trial status is completed. This product is registered under clinical trial identifier NCT00494832. Target conditions include Spine Surgery.
What happened to similar drugs?
2 of 2 similar drugs in Spine Surgery were approved
Approved (2) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00494832 | Pre-clinical | Completed |
Competing Products
2 competing products in Spine Surgery
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Sugammadex + Neostigmine + Glycopyrrolate + Rocuronium | Merck | Approved | 50 |
| sugammadex + Neostigmine | Merck | Approved | 43 |